The Dantrolene Sodium for Injection, cataloged under National Stock Number 6505-01-653-1569, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Eagle Pharmaceuticals, Inc.. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-653-1569 |
| Primary Part Number | NDC42367-0540-32 |
| Item Name | Dantrolene Sodium for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Eagle Pharmaceuticals, Inc. |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 250.0 MILLIGRAMS OF ACTIVE INGREDIENT |
| Usual Dose | 2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Active Medicament Medicinal Strength | 250.0 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC42367-0540-32 | Cardinal Health, Inc. (USA) |
| NDC42367-0540-32 PRIMARY | Eagle Pharmaceuticals, Inc. (USA) |
| NDC42367-0540-32 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM162633 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1398188 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-653-1569 is a Dantrolene Sodium for Injection, manufactured by Eagle Pharmaceuticals, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-653-1569 has 3 manufacturer part numbers on file: NDC42367-0540-32 (Cardinal Health, Inc.), NDC42367-0540-32 (Eagle Pharmaceuticals, Inc.), NDC42367-0540-32 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC42367-0540-32: Administration: INTRAVENOUS; Primary Container Content Quantity: 250.0 MILLIGRAMS OF ACTIVE INGREDIENT; Usual Dose: 2.5 MG/KG ADMINISTERED INTRAVENOUSLY OVER A PERIOD OF AT LEAST 1 MINUTE, STARTING APPROXIMATELY 75 MINUTES PRIOR TO SURGERY; Primary Container Type: VIAL. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.